GH
Guardant Health, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$157.26
−2.35%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 13.61x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -94.69x
- Price / sales
- 17.84x
- Price / cash flow
- -113.96x
Enterprise value
- Enterprise value
- $21.7B
- EV / sales
- 18.38x
- EV / EBITDA
- -52.89x
- EV / EBIT
- -46.25x
- Market cap
- $21.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026